A DLL3/CD3/CD137 trispecific T cell engager shows potent antitumor activity in small cell lung cancer models

被引：2
|
作者：
Mikami, Hirofumi
Feng, Shu
Naoi, Sotaro
Azuma, Yumiko
Kayukawa, Yoko
Tsunenari, Toshiaki
Asanuma, Kentaro
Iwabuchi, Ryutaro
Nagano, Hiroaki
Shinozuka, Junko
Yamazaki, Masaki
Kuroi, Haruka
Gan, Siok Wan
Chichili, Priyanka
Shimizu, Shun
Matsuda, Yutaka
Ishii, Shinya
Kamikawaji, Shogo
Kinoshita, Yasuko
Shimizu, Yuichiro
Sakamoto, Akihisa
Muraoka, Masaru
Takahashi, Noriyuki
Kawa, Tatsuya
Shiraiwa, Hirotake
Kashima, Kenji
Mimoto, Futa
Kamata-Sakurai, Mika
Kitazawa, Takehisa
Igawa, Tomoyuki
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1872
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1872
引用
收藏
页数：3
相关论文
共 50 条
  • [1] FDA approves first DLL3 x CD3 bispecific T-cell engager for lung cancer
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (07) : 487 - 487
  • [2] Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
    Mikami, Hirofumi
    Feng, Shu
    Matsuda, Yutaka
    Ishii, Shinya
    Naoi, Sotaro
    Azuma, Yumiko
    Nagano, Hiroaki
    Asanuma, Kentaro
    Kayukawa, Yoko
    Tsunenari, Toshiaki
    Kamikawaji, Shogo
    Iwabuchi, Ryutaro
    Shinozuka, Junko
    Yamazaki, Masaki
    Kuroi, Haruka
    Ho, Samantha Shu Wen
    Gan, Siok Wan
    Chichili, Priyanka
    Pang, Chai Ling
    Yeo, Chiew Ying
    Shimizu, Shun
    Hironiwa, Naoka
    Kinoshita, Yasuko
    Shimizu, Yuichiro
    Sakamoto, Akihisa
    Muraoka, Masaru
    Takahashi, Noriyuki
    Kawa, Tatsuya
    Shiraiwa, Hirotake
    Mimoto, Futa
    Kashima, Kenji
    Kamata-Sakurai, Mika
    Ishikawa, Shumpei
    Aburatani, Hiroyuki
    Kitazawa, Takehisa
    Igawa, Tomoyuki
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (06) : 719 - 730
  • [3] Improving efficacy of DLL3-targeted T cell engagers with CD3/CD137 dual specific Fabs to treat small cell lung cancer
    Mikami, Hirofumi
    CANCER SCIENCE, 2024, 115 : 2064 - 2064
  • [4] Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas
    Wermke, Martin
    Felip, Enriqueta
    Gambardella, Valentina
    Kuboki, Yasutoshi
    Morgensztern, Daniel
    Hamed, Zohra Oum'
    Liu, Meiruo
    Studeny, Matus
    Owonikoko, Taofeek K.
    FUTURE ONCOLOGY, 2022, 18 (24) : 2639 - 2649
  • [5] A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer
    Hipp, Susanne
    Voynov, Vladimir
    Drobits-Handl, Barbara
    Giragossian, Craig
    Trapani, Francesca
    Nixon, Andrew E.
    Scheer, Justin M.
    Adam, Paul J.
    CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5258 - 5268
  • [6] Preliminary phase I results from a first-in-human study of ZG006, a trispecific anti-T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer or neuroendocrine carcinoma
    Wang, Q.
    Chai, X.
    Lin, R.
    Zheng, L.
    Cao, D.
    Qu, X.
    Liu, L.
    Wu, L.
    Mou, H.
    Xu, Q.
    Shi, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S532 - S533
  • [7] SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
    Kamikawa, Takayuki
    Kimura, Naoki
    Ishii, Shinya
    Muraoka, Masaru
    Kodama, Tatsushi
    Taniguchi, Kenji
    Yoshimoto, Moe
    Miura-Okuda, Momoko
    Uchikawa, Ryo
    Kato, Chie
    Shinozuka, Junko
    Akai, Sho
    Naoi, Sotaro
    Tomioka, Nanami
    Nagaya, Nishiki
    Pang, Chai Ling
    Garvita, Gupta
    Feng, Shu
    Shimada, Mei
    Kamata-Sakurai, Mika
    Aburatani, Hiroyuki
    Kitazawa, Takehisa
    Igawa, Tomoyuki
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
  • [8] DLL3 TriTCE Co-Stim: A next generation trispecific T cell engager with integrated CD28 costimulation for the treatment of DLL3-expressing cancers
    Repenning, Peter
    Lau, Desmond
    Hernaez, Diana C.
    Robinson, Alec
    Escanda, Diego P.
    Rocha, Mariana
    Moreno, Begonia S.
    Zhang, John
    Shao, Polly
    Escalante, Nichole
    Newhook, Lisa
    Bhojane, Purva
    Piscitelli, Chayne L.
    Moore, Paul A.
    Von Kreudenstein, Thomas Spreter
    Weisser, Nina E.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] DLL3: an emerging target in small cell lung cancer
    Owen, Dwight H.
    Giffin, Michael J.
    Bailis, Julie M.
    Smit, Marie-Anne Damiette
    Carbone, David P.
    He, Kai
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [10] Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
    Sangsuwannukul, Thanich
    Supimon, Kamonlapat
    Chieochansin, Thaweesak
    Choomee, Kornkan
    Sujjitjoon, Jatuporn
    Junking, Mutita
    Yenchitsomanus, Pa-Thai
    PLOS ONE, 2022, 17 (03):
12345